CureVac seeks Covid-19 shot approval in Switzerland
German drugmaker CureVac has submitted an application for the approval of its Covid-19 mRNA vaccine with Swiss drugs regulator Swissmedic. Until now Switzerland has approved three vaccines, two of which are being used.
Switzerland has already placed orders for five million doses of CureVac’s mRNA vaccine, which is similar to those from Moderna and Pfizer that are already being administered across the country.
The submission is part of a rolling review procedure to “evaluate the scientific data as soon as they become available”, Swissmedic said.
“CureVac can forward documentation on its vaccine candidate on an ongoing basis without having to await the final results of the clinical trials,” it said. However, it is unclear how long the review will take.
“The duration of the rolling review will depend on the completeness of the data submitted by CureVac and the results of the clinical trials, and cannot therefore be predicted,” Swissmedic said.
Swiss drugmaker Novartis has agreed to help make CureVac’s vaccine at a plant in neighbouring Austria.
AstraZeneca status
Although AstraZeneca was the first company to start the review process in Switzerland in early October for its vaccine, regulators have said they still don’t have enough information to approve the British company’s shot.
Swiss authorities have ordered nearly 36 million vaccine doses from Pfizer/BioNTech (6 million), Moderna (13.5 million), AstraZeneca (5.3 million), CureVac (5 million) and Novavax (6 million) for the population of 8.6 million people. So far, there are two vaccines approved and available in the country, those from Pfizer/BioNTech and Moderna. Johnson & Johnson’s single-dose vaccine has also been approved but has not been ordered by the Federal Office of Public Health. Others should follow.
Since January 4 (vaccinations began in late December) the government has started to roll out its vaccination planExternal link. It has set an ambitious target: to inoculate six million people or 70% of the population – on a voluntary basis – by summer, or up to 70,000 vaccine shots per day. The vaccination roll-out is being slowly scaled up. The programme has been delayed by vaccine production and delivery problems.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Macron will attend Swiss summit on Ukraine, says Zelensky
This content was published on
French President Emmanuel Macron will attend the peace conference on Ukraine at the Swiss Bürgenstock resort next month, according to Volodymyr Zelensky.
Top politician tells ‘corrupt’ Eurovision to stay away from Bern
This content was published on
A social media post by the president of Bern’s cantonal government critical of the Eurovision Song Contest has created waves and will be discussed in the cantonal parliament.
Swiss centre records over 200 victims of human trafficking
This content was published on
Last year 317 people took part in a protection programme run by the Specialist Unit for Trafficking in Women and Women’s Migration (FIZ) in German-speaking Switzerland.
This content was published on
The Geneva-based International Committee of the Red Cross (ICRC) and partners are opening a field hospital in southern Gaza on Tuesday.
Lack of smartphone sustainability in Switzerland hits environment
This content was published on
Almost half of all Swiss citizens hang on to their old smartphones, tablets and laptops, according to the Federal Statistical Office.
Police clear out pro-Palestinian students protesting in Geneva
This content was published on
The police intervened early on Tuesday to dislodge pro-Palestinian students who had been occupying the University of Geneva for almost a week.
New gel developed in Zurich renders alcohol harmless
This content was published on
A newly developed gel composed of whey proteins breaks down alcohol in the body and could reduce its harmful and intoxicating effects in humans.
Pro-Palestine protests extend to Basel and Fribourg universities
This content was published on
Demonstrators called for an academic boycott of all Israeli institutions and disassociation with Chaim Weizmann, the first Israeli president.
Data on AstraZeneca vaccine insufficient for Swiss approval
This content was published on
Swissmedic says it has not yet received enough robust data from clinical trials to give the green light to the Covid-19 vaccine.
This content was published on
Media reports indicate that vaccinating everyone who wants to by summer relies on meeting ambitious vaccine delivery targets in spring.
Covid-19 vaccine: Why we still have a long wait ahead
This content was published on
Countries have started rolling out a Covid-19 vaccine, but it will likely take years to manufacture doses at the scale needed to reach the masses.
Swiss regulator warns of fake Covid-19 vaccines online
This content was published on
Scammers are selling dangerous fake coronavirus vaccines on the internet, Switzerland’s health regulator Swissmedic warned on Tuesday.
Swiss factory rushes to prepare for Moderna Covid-19 vaccine
This content was published on
Workers are racing to set up production lines at the Lonza factory in Visp to be able to start making a vaccine for US firm Moderna later this year.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.